Navigating key news stories in pharma

Featured Stories

Featured
Balancing Innovation with Integrity in Pharma Packaging
Strategy
Balancing Innovation with Integrity in Pharma Packaging
Strategy

As pharmaceutical packaging evolves to incorporate more patient-centric designs, overcome increasingly complex formulations, and undergo a digital transformation, safety and compliance remain non-negotiables.

Read More →
Strategy
News
Balancing Innovation with Integrity in Pharma Packaging
Strategy
Balancing Innovation with Integrity in Pharma Packaging
Strategy

As pharmaceutical packaging evolves to incorporate more patient-centric designs, overcome increasingly complex formulations, and undergo a digital transformation, safety and compliance remain non-negotiables.

Strategy
Committing to a Sustainable Future in Biomanufacturing
Future Biopharma
Committing to a Sustainable Future in Biomanufacturing
Future Biopharma

With an increasing spotlight on sustainability, it is increasingly important for industry-wide sustainability practices to be implemented to ensure transformative change is achieved.

Future Biopharma
Sanner: Enhancing Patient-Friendly Packaging
Sanner: Enhancing Patient-Friendly Packaging

In this white paper, Chris Gilmore, Director of Sales, Sanner America, introduces the company’s new packaging platform, TabTec® CR, which is a convenient solution for oral solid dosage products with integrated desiccant and child-resistant opening.

Dealmaking

Featured
BioDuro, Atombeat Join Forces to Speed Up Peptide Drug Discovery
BioDuro, Atombeat Join Forces to Speed Up Peptide Drug Discovery

This partnership will leverage BioDuro’s expertise and Atombeat’s in silico modeling know-how to launch an AI-powered platform that allows for accelerated development of next-generation peptides.

MetaVia, Syntekabio Partner Up to Expand Therapeutic Potential of Oral GPR119 Agonist
MetaVia, Syntekabio Partner Up to Expand Therapeutic Potential of Oral GPR119 Agonist

The companies will work together, leveraging Syntekabio’s AI prediction platform for virtual screening to uncover new, high-potential indications for MetaVia’s DA-1241 oral therapy.

GSK, Hengrui Pharma Partner on Development of Up to 12 Innovative Medicines
GSK, Hengrui Pharma Partner on Development of Up to 12 Innovative Medicines

The strategic collaboration will also provide GSK with an exclusive worldwide license for Hengrui’s potential best-in-class PDE3/4 inhibitor, which is in clinical development as an add-on maintenance treatment for COPD.

Boehringer Strikes Up Deal with Re-Vana to Deliver Ophthalmic Pipeline
Boehringer Strikes Up Deal with Re-Vana to Deliver Ophthalmic Pipeline

The strategic collaboration and license agreement is potentially worth more than USD 1 billion and offer patients less burdensome treatment regimens through sustained ocular delivery of therapies.

Future Biopharma

Featured
Committing to a Sustainable Future in Biomanufacturing
Committing to a Sustainable Future in Biomanufacturing

With an increasing spotlight on sustainability, it is increasingly important for industry-wide sustainability practices to be implemented to ensure transformative change is achieved.

Making the Right Capacity Decisions at the Biomanufacturing Crossroads
Making the Right Capacity Decisions at the Biomanufacturing Crossroads

While biomanufacturing has ample capacity, a funding downturn and workforce shortages have created a paradoxical situation, putting pressure on sponsors’ decisions when it comes to choosing their manufacturing partners.

Approaching a Significant Transformation
Approaching a Significant Transformation

While there have been promising advances in terms of technologies to help the development and manufacture of next-gen therapies, limitations remain; but, it is likely that AI will be revolutionary for development in the near future.

Investing in Innovation to Capture Next-Gen Therapy Potential
Investing in Innovation to Capture Next-Gen Therapy Potential

Advanced technologies, while important for the successful development and manufacture of next-gen therapies, are still a long way off being impactful, meaning more investment is needed to reap the rewards of these promising treatments.
Bend Bioscience

R&D

Featured
CPTx and NanoCell Win European Funding for QUIET-CAR Project
CPTx and NanoCell Win European Funding for QUIET-CAR Project

The grant money will be used by the biotechs to develop innovative targeted lipid nanoparticles that contain novel immune-silent DNA constructs for in vivo CAR T therapy.

Preclinical Data Demonstrates Therapeutic Efficacy of Enveric’s Lead Candidate
Preclinical Data Demonstrates Therapeutic Efficacy of Enveric’s Lead Candidate

The company’s research in a well-established rodent model has shown that EB-003 has potential as an effective treatment for post-traumatic stress disorder, representing an opportunity in an underserved market.

Nanoform Receives Funding to Advance Clinical Development of Nanoapalutamide
Nanoform Receives Funding to Advance Clinical Development of Nanoapalutamide

Business Finland is providing Nanoform with a EUR 5 million R&D loan to be used to accelerate the clinical development of the nanoformulated version of apalutamide through to the pivotal bioequivalence study.

Dicot Pharma Unveils MoA Findings for Potency Therapy
Dicot Pharma Unveils MoA Findings for Potency Therapy

The latest studies on the mechanism of action for LIB-01 have demonstrated that the drug targets the underlying nerves and vascular structures that are involved in penile erections.

Expansion

Featured
Cohance Lifesciences Invests Heavily in Capabilities in India and U.S.
Cohance Lifesciences Invests Heavily in Capabilities in India and U.S.

The strategic investments by the CRDMO, which are aligned with its long-term strategy, will strengthen its integrated oligonucleotide platform and capabilities to delivery ADC solutions.

Bionova to Open pDNA Development and Production Facility in Texas
Bionova to Open pDNA Development and Production Facility in Texas

The location of the facility has been purposefully chosen to be as central as possible to cell and gene therapy companies located across the U.S. and will allow the company to meet growing demand for pDNA development and manufacturing services.

ESTEVE Expands U.S. CDMO Capabilities Through Acquisition of Regis Technologies
ESTEVE Expands U.S. CDMO Capabilities Through Acquisition of Regis Technologies

Through this acquisition, ESTEVE will expand its contract development and manufacturing services for small-molecule APIs from pre-clinical through to commercial manufacturing within the U.S.

Circio Expands into Novel Lab Facilities in Stockholm
Circio Expands into Novel Lab Facilities in Stockholm

Marking a strategic move for the company, the expansion will enable acceleration of pre-clinical development of the circVec circular RNA expression data platform.

Strategy

Featured
Balancing Innovation with Integrity in Pharma Packaging
Balancing Innovation with Integrity in Pharma Packaging

As pharmaceutical packaging evolves to incorporate more patient-centric designs, overcome increasingly complex formulations, and undergo a digital transformation, safety and compliance remain non-negotiables.

Cohance Appoints Yann D’Herve as New CEO
Cohance Appoints Yann D’Herve as New CEO

D’Herve has succeeded Dr. Singh, bringing a wealth of industry experience to the position, having previously served in senior positions at Evonik.

Reinventing Gene Therapy?
Reinventing Gene Therapy?

Recent fatalities in clinical trials for gene therapies have led to greater regulatory scrutiny and concerns over safety, particularly in relation to the use of viral vectors, leading industry to question whether a potential therapeutic reinvention is needed.

Restructuring Efforts See Rocket Focus on Cardiovascular Programs
Restructuring Efforts See Rocket Focus on Cardiovascular Programs

In efforts to position itself for long-term growth, Rocket is reducing its company headcount, undergoing a structural reorganization, and prioritizing late-stage AAV cardiovascular programs.

Regulatory

Featured
Viatris’ Generic Iron Sucrose Gains FDA Nod
Viatris’ Generic Iron Sucrose Gains FDA Nod

FDA has granted approval to Viatris for its generic intravenous iron replacement product as a treatment of iron deficiency anemia in adult and pediatric patients with chronic kidney disease.

FDA Accepts GSK’s Gepotidacin for Priority Review
FDA Accepts GSK’s Gepotidacin for Priority Review

If the oral antibiotic gains regulatory approval, patients who are 12 years of age and older in the U.S. suffering from urogenital gonorrhea will have an alternative, non-invasive treatment option.

Sean Keveney Named FDA’s Next Chief Counsel
Sean Keveney Named FDA’s Next Chief Counsel

This latest FDA leadership appointment comes as the agency focuses on balancing regulatory challenges with opportunities for accelerated patient access.

Apellis Gains FDA Nod for C3G and Primary IC-MPGN Treatment
Apellis Gains FDA Nod for C3G and Primary IC-MPGN Treatment

Pegcetacoplan (EMPAVELI), which was shown to be safe and effective in a Phase III clinical trial, is now approved for the treatment of U.S. patients 12 years and older with C3G and primary IC-MPGN.

Upcoming Events

Featured
CE Pharm 2025

The goal of this Symposium is to provide a forum for the discussion of recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide, and small molecule pharmaceuticals.

Fierce Pharma Week 2025

This September in Philadelphia, the brightest minds in marketing, commercialization, medical affairs, and PR & communications are coming together for one unmissable week of insight, innovation, and industry-shaping strategy.

Precision in Drug Discovery & Preclinical Summit 2025

Join the 26th Precision in Drug Discovery & Preclinical Summit (Barcelona, Spain, Europe) PDDP for a two-day journey into the insightful world of drug discovery and preclinical drug development.